The company is once again angling to bring its technology to the U.S. market.
News & Features
Less than a month after FDA alerted doctors of patient deaths related to balloon-based obesity procedures, a newer version of Apollo’s Orbera balloon has been approved in Europe.
MD+DI and Qmed are joining forces to become a one-stop shop for medtech news and supplier connections.
Teleflex agreed to pay up to $1.1 billion for NeoTract, a hyper-growth company in the urological device market.
ExThera Medical's new blood filter technology received Expedited Access Pathway (EAP) designation, accelerating the FDA approval process for the device ahead of clinical use.
Medtronic entered the next phase of its partnership with Mazor by putting up an additional $40 million equity investment and assuming the global distribution of the Mazor X robot. Analysts say the deal is positive for both companies but negative for competitors like NuVasive that lack a robotics system.
Here’s what was new in the world of medical device suppliers during the week of August 27. This is a compilation of the latest news from suppliers in the medical device industry. If you have news you’d like to submit for potential inclusion in this weekly roundup, please send a press release and...
Qmed is joining forces with MD+DI to become a one-stop shop to keep you up to date on the latest medtech news and connect you with suppliers and service providers. Qmed has been connecting you with medtech suppliers and keeping you informed about the latest industry news since 2010, and now your...
Selection of a suitable adhesive for a medical device is challenging because of the wide variety of adhesive types, performance characteristics, and an ever-expanding range of use scenarios.
A new FDA approval could help Becton, Dickinson and Company shareholders see the long-term value of the company's $24 billion pending acquisition of C.R. Bard.
Linking the experimental process to the design controls defined by FDA can help ensure an effective and efficient new product development effort, as well as a competitive market advantage.